1. Home
  2. LUNG vs ARQ Comparison

LUNG vs ARQ Comparison

Compare LUNG & ARQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • ARQ
  • Stock Information
  • Founded
  • LUNG 1995
  • ARQ 1996
  • Country
  • LUNG United States
  • ARQ United States
  • Employees
  • LUNG N/A
  • ARQ N/A
  • Industry
  • LUNG Industrial Specialties
  • ARQ
  • Sector
  • LUNG Health Care
  • ARQ
  • Exchange
  • LUNG Nasdaq
  • ARQ NYSE
  • Market Cap
  • LUNG 299.3M
  • ARQ 208.8M
  • IPO Year
  • LUNG 2020
  • ARQ N/A
  • Fundamental
  • Price
  • LUNG $7.85
  • ARQ $4.81
  • Analyst Decision
  • LUNG Strong Buy
  • ARQ Strong Buy
  • Analyst Count
  • LUNG 7
  • ARQ 1
  • Target Price
  • LUNG $12.64
  • ARQ $9.00
  • AVG Volume (30 Days)
  • LUNG 464.2K
  • ARQ 289.0K
  • Earning Date
  • LUNG 04-30-2025
  • ARQ 03-05-2025
  • Dividend Yield
  • LUNG N/A
  • ARQ N/A
  • EPS Growth
  • LUNG N/A
  • ARQ N/A
  • EPS
  • LUNG N/A
  • ARQ N/A
  • Revenue
  • LUNG $83,789,000.00
  • ARQ $108,959,000.00
  • Revenue This Year
  • LUNG $17.96
  • ARQ $32.45
  • Revenue Next Year
  • LUNG $18.35
  • ARQ $16.18
  • P/E Ratio
  • LUNG N/A
  • ARQ N/A
  • Revenue Growth
  • LUNG 22.01
  • ARQ 9.86
  • 52 Week Low
  • LUNG $5.46
  • ARQ $4.01
  • 52 Week High
  • LUNG $10.01
  • ARQ $8.26
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 52.84
  • ARQ 38.20
  • Support Level
  • LUNG $7.65
  • ARQ $4.83
  • Resistance Level
  • LUNG $8.12
  • ARQ $4.89
  • Average True Range (ATR)
  • LUNG 0.56
  • ARQ 0.29
  • MACD
  • LUNG -0.06
  • ARQ 0.03
  • Stochastic Oscillator
  • LUNG 46.86
  • ARQ 63.67

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About ARQ ARQ INC

Arq Inc is an environmental technology company principally engaged in the sale of consumable air, water, and soil treatment solutions including activated carbon (AC) and chemical technologies. The company manufactures and sells activated carbon and other chemicals used to capture and remove contaminants for the coal-fired power generation, industrial, municipal water and air, water and soil treatment and remediation markets. Some of the products in its portfolio are Powdered Activated Carbon, Granula Activated Carbon, and Colloidal Carbon Product among others.

Share on Social Networks: